Combination pills for high blood pressure may simplify treatment, improve long-term health

Combining two or more medications into one pill may help adults with high blood pressure achieve optimal blood pressure goals more quickly and reduce their risk of heart attack and stroke, according to a new American Heart Association scientific statement

2025-12-15

(Press-News.org) Statement Highlights:

Single-pill medications that combine two or more blood pressure medications could simplify treatment to help more adults with high blood pressure achieve target blood pressure levels faster and maintain blood pressure goals long-term compared with patients taking multiple, separate pills daily. The use of combination medications is linked to a lower risk of heart attack, stroke, heart failure-related hospitalizations and death, as well as to improved quality of life and reduced long-term costs for patients and the health care system. More research is needed to understand the impact of single-pill combination medications for people with higher cardiovascular risks — people with resistant or secondary hypertension, or other chronic conditions such as kidney disease, Type 1 or Type 2 diabetes or heart failure, according to the new scientific statement. Embargoed until 4:00 a.m. CT/5:00 a.m. ET Monday, Dec. 15, 2025

DALLAS, Dec. 15, 2025 — Taking one pill that combines two or more blood pressure medications may help adults with high blood pressure (also known as hypertension) lower their blood pressure level faster and more effectively than taking multiple medications separately, and it may also reduce the risk of heart attack and stroke, according to a new scientific statement published today in the American Heart Association’s journal Hypertension.

The new scientific statement, Single-Pill Combination Therapy for the Management of Hypertension, details the latest clinical evidence surrounding the use of single-pill combination medications for patients with high blood pressure, strategies to implement single-pill combinations into clinical practice and knowledge gaps that require further investigation.

According to the 2025 American Heart Association Statistical Update, nearly half of U.S. adults, about 122 million people, have high blood pressure, defined as blood pressure measures equal to or higher than 130/80 mm Hg. High blood pressure is the #1 modifiable risk factor for cardiovascular disease and it is a leading cause of heart attack, stroke, heart failure, kidney disease, cognitive decline and dementia. The recently published 2025 AHA/ACC High Blood Pressure Guideline recommends combining healthy lifestyle behaviors and early treatment with one or more blood pressure medications to lower blood pressure, if necessary. For people with blood pressure levels 140/90 mm Hg or higher (stage 2 hypertension), the guideline recommends beginning treatment with two medications at once – preferably in a single combination pill.

“Most people with high blood pressure need two or more blood pressure medications to reach target blood pressure measurements; however, taking multiple pills each day can be confusing or hard to keep up with,” said Jordan B. King, Pharm.D., M.S., chair of the scientific statement writing group and an associate professor of population health sciences at the University of Utah in Salt Lake City. “Single-pill combination pills are valuable tools to manage high blood pressure. Individuals taking a single combination pill are able to achieve optimal blood pressure levels sooner than peers who take the same medications in separate pills.”

The statement authors note that single-pill combination medications are not the same as a “polypill.” Single-pill combination medications combine two or more blood pressure medications into a single pill, whereas polypills combine one or more blood pressure medications with statins (cholesterol-lowering medication) and/or aspirin. Polypills aim to reduce cardiovascular risk for patients requiring multiple preventive therapies.

There are several types of effective medications to treat high blood pressure, including angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), calcium channel blockers and thiazide-type diuretics which are first-line recommended medications. However, less than 50% of U.S. adults who have been diagnosed with and are being treated for high blood pressure achieve the recommended blood pressure goal of less than 130/80 mm Hg.

“High blood pressure is challenging to manage for many people, and many people do not take their medication consistently. They may not be aware that untreated high blood pressure increases their risk of developing heart disease and other cardiovascular conditions—and that achieving and maintaining target blood pressure can significantly reduce their risk,” King said.

Benefits of Combination Medications

Simplified, faster treatment: A step-by-step prescribing approach involving multiple pills and adjusting doses takes time to achieve blood pressure targets. It is easier for people to consistently take medications as directed when there are fewer pills to manage. Using a single-pill combination medication of two or more blood pressure-lowering medications may simplify the process and help adults with high blood pressure reach target blood pressure levels more quickly. Streamlined prescribing: Single-pill combinations streamline the prescribing process for clinicians by helping to reduce uncertainty around which medications to start and at what dosage. For most people with high blood pressure that requires medications, which could include some with stage 1 hypertension, the statement encourages clinicians to start with the preferred choice of a combination pill: either an ACE inhibitor or an ARB plus a calcium channel blocker. Improved long-term heart health: Observational studies with follow-up periods ranging from 1-5 years have linked single-pill combination medication use with a 15%-30% lower risk of major adverse cardiovascular events, such as heart attack, stroke, heart failure-related hospitalizations and death. Prevention of cardiovascular events is also linked to a longer and improved quality of life. Lower Costs: According to the American Heart Association’s 2025 Heart Disease and Stroke Statistics, the annual direct and indirect costs of cardiovascular disease in the United States were an estimated $417.9 billion. Improving blood pressure control could help lower health care costs for patients and health care organizations over time. Recent studies have found that combination pills are more cost-effective than taking the same medications in separate pills. Barriers to Widespread Adoption

Prescriber awareness and concerns: Clinicians may have limited awareness of available combination therapies. Concerns about reduced flexibility in dosage adjustments have been also identified as a barrier to prescribing single-pill medications. Some clinicians prefer separate pills because it allows easier adjustment or discontinuation of an individual medication if adverse side effects occur. Affordability and accessibility: Use of single-pill combination medications may be restricted by health insurance coverage and higher out-of-pocket costs for patients. Many insurers, including Medicare and Medicaid, continue to require the use of equivalent combinations prescribed as separate pills, despite the growing body of evidence demonstrating the cost-effectiveness of combination medications. Streamlining insurance coverage processes and lowering copayments for single-pill medications could help expand access for people with high blood pressure. Limited evidence for high-risk populations: More research is needed to evaluate the safety and effectiveness of single-pill combination medications for people at higher risk of cardiovascular disease, such as individuals with resistant or secondary hypertension, chronic kidney disease, Type 1 or Type 2 diabetes or heart failure and older adults. Studies examining the efficacy of single-pill combinations among higher-risk groups will better inform treatment in more complex cases and help guide clinical decision-making in the future. Currently, there are approximately 200 unique combinations of blood pressure medications used by patients in the U.S. The four most commonly used medications are currently available as single-pill combinations. Expanding options for the medications combined within single-pill combination medications and developing additional triple and quadruple combinations may further simplify treatment and improve patient outcomes, the statement notes.

“If single-pill combinations were the norm rather than the exception, there could be a meaningful improvement in blood pressure control across the population, which could significantly reduce the risk of heart attacks and strokes. In the long run, better blood pressure control lowers health care costs for patients and society, enhances quality of life and improves health outcomes for the millions of people with high blood pressure,” King said.

This scientific statement was prepared by the volunteer writing group on behalf of the American Heart Association’s Council on Hypertension; the Council on Cardiovascular and Stroke Nursing; and the Council on Clinical Cardiology. American Heart Association scientific statements promote greater awareness about cardiovascular diseases and stroke issues and help facilitate informed health care decisions. Scientific statements outline what is currently known about a topic and what areas need additional research. While scientific statements inform the development of guidelines, they do not make treatment recommendations. American Heart Association guidelines provide the Association’s official clinical practice recommendations.

Co-authors are Vice-Chair Robert D. Brook, M.D.; Jaejin An, B.Pharm., Ph.D.; Brandon K. Bellows, Pharm.D., M.S.; Jordana B. Cohen, M.D., M.S.C.E., FAHA; Yvonne Commodore-Mensah, Ph.D., M.H.S., R.N., FAHA; Lama Ghazi, M.D., Ph.D.; and Aisha T. Langford, Ph.D. Authors’ disclosures are listed in the manuscript.

The Association receives more than 85% of its revenue from sources other than corporations. These sources include contributions from individuals, foundations and estates, as well as investment earnings and revenue from the sale of our educational materials. Corporations (including pharmaceutical, device manufacturers and other companies) also make donations to the Association. The Association has strict policies to prevent any donations from influencing its science content and policy positions. Overall financial information is available here.

Additional Resources:

Available multimedia is on right column of release link. Spanish news release After Dec. 15, 2025, view the manuscript online. American Heart Association news release: New high blood pressure guideline emphasizes prevention, early treatment to reduce CVD risk (Aug. 2025) American Heart Association news release: Heart disease remains leading cause of death as key health risk factors continue to rise (Jan. 2025) American Heart Association health information: High Blood Pressure and High Blood Pressure Resources American Heart Association health initiative: Target: BPTM Follow American Heart Association/American Stroke Association news on X @HeartNews Follow news from the American Heart Association’s Hypertension journal @HyperAHA ###

About the American Heart Association

The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public’s health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on heart.org, Facebook, X or by calling 1-800-AHA-USA1.

END

ELSE PRESS RELEASES FROM THIS DATE:

Immune system keeps mucosal fungi in check

2025-12-15

The microbiome not only consists of bacteria, but also of fungi. Most of them support human and animal health. However, some fungi also have pathogenic potential. For instance, the yeast Candida albicans can grow in an uncontrolled manner on the oral mucosa, causing oral thrush. In severe cases by growing in a filamentous form it can enter the blood stream and cause systemic infections, which account for over one million deaths per year. This happens primarily in people with a weakened immune system on intensive care units, for instance individuals who are immunosuppressed ...

Neurons within the brain use simple rules to localize genetic messages

2025-12-15

Scientists found that messenger RNA (mRNA) molecules that carry genetic instructions to the far reaches of neurons in the brain tend to cluster together mostly because they are abundant, not because they move in coordinated groups. The discovery, published in the Society for Neuroscience journal eNeuro, helps explain how neurons, which have some of the longest processes of any cells in the body, manage genetic instructions long distances from where they are made. This fundamental process is critical to support neuronal communication and the modifications ...

Electrodes created using light

2025-12-15

Visible light can be used to create electrodes from conductive plastics completely without hazardous chemicals. This is shown in a new study carried out by researchers at Linköping and Lund universities, Sweden. The electrodes can be created on different types of surfaces, which opens up for a new type of electronics and medical sensors. “I think this is something of a breakthrough. It’s another way of creating electronics that is simpler and doesn’t require any expensive equipment,” says Xenofon Strakosas, assistant professor at the Laboratory of Organic Electronics, LOE, at Linköping University. LOE’s researchers are working with ...

Second-hand gift-giving is a well-deliberated decision

2025-12-15

Fair price, treasure hunting, i.e., the thrill of finding something rare or valuable, as well as ethical and ecological reasons motivate consumers’ intentions to buy second-hand gifts, a recent study from the University of Eastern Finland finds. Administered to users of one of Finland’s most popular consumer-to-consumer online marketplaces, Tori.fi, the survey also shows that an intention to buy a second-hand gift often leads to an actual purchase decision. “Our findings indicate that buying second-hand gifts is a well-thought-through decision rather than an impulsive one. It involves the ...

How human interaction drove evolution to make bears less aggressive

2025-12-15

A new paper in Molecular Biology and Evolution, published by Oxford University Press, reports that Italian bears living in areas with many villages evolved and became smaller and less aggressive. Humans have long shaped the environments in which they live, dramatically affecting ecosystems and biodiversity. Habitat change and overuse are among the human activities with the greatest impacts on wildlife, often leading to population declines and/or shifts in selective pressures, thus influencing how a species evolves. The Apennine brown bear, Ursus arctos marsicanus, is a small and isolated population found only in ...

National Poll: Few parents offer teens guidance on healthy eating during holiday season

2025-12-15

ANN ARBOR, Mich. – As teens gain more independence in their food choices, many parents struggle to navigate conversations about nutrition —which could be especially important during the holidays, when celebrations often center around meals. While parents recognize concerns about their teen’s eating habits, few provide concrete strategies to help them make healthy decisions during festive gatherings, according to the University of Michigan Health C.S. Mott Children’s Hospital National Poll on Children’s Health. One in three parents say it’s difficult to talk with their teen about food and weight, rising ...

Cannabis derivatives could provide new ovarian cancer treatments

2025-12-15

In the future, scientists could use drugs made from cannabis to fight ovarian cancer. A team of scientists testing the effects of two chemical compounds sourced from cannabis on ovarian cancer cells have found that both show promising anti-cancer effects. While more research will be required to turn these results into drugs which can be delivered to patients, these findings are an important opportunity to develop effective new therapies for a cancer which is hard to diagnose and even harder to treat. “Ovarian cancer remains one of the deadliest gynecological malignancies, characterized by late diagnosis, high recurrence ...

Raising strong yeast as a petroleum substitute

2025-12-15

As fossil fuels rise in cost and green initiatives gain traction, alternative methods for producing useful compounds using microorganisms have the potential to become sustainable, environmentally friendly technologies. One such process involves the common bread yeast, Saccharomyces cerevisiae (S. cerevisiae), to produce 2,3-butanediol (2,3-BDO), an organic compound often used in pharmaceuticals and cosmetics. However, this yeast has a low tolerance for 2,3-BDO under high concentrations, which leads to a decline in its production ability and hinders the mass commercialization ...

Clues to the origin of hot Jupiters hidden in their orbits

2025-12-15

The first exoplanet ever discovered in 1995 was what we now call a “hot Jupiter”, a planet as massive as Jupiter with an orbital period of just a few days. Today, hot Jupiters are thought to have formed far from their stars—similar to Jupiter in our Solar System—and later migrated inward. Two main mechanisms have been proposed for this migration: (1) high-eccentricity migration, in which a planet’s orbit is disturbed by the gravity of other celestial bodies and subsequently circularized by tidal forces near the star; and (2) disk migration, in which ...

Canada’s reduced pledge to Global Fund will impact domestic health

2025-12-15

Canada should rethink its reduced pledge to the Global Fund to protect the health of people in Canada as well as around the globe, argue authors in an editorial published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.252036. In November, Canada reduced its pledge by 16% to the Global Fund, which fights AIDS, tuberculosis (TB), and malaria and strengthens pandemic preparedness. Two related commentaries in the same issue describe increases in tuberculosis in Canada and the backsliding in addressing HIV/AIDS around the world and potential ...

LAST 30 PRESS RELEASES:

Two Keck Medicine of USC Hospitals named Leapfrog Top Teaching Hospitals

World-first discovery uncovers how glioblastoma tumours dodge chemotherapy, potentially opening the door to new treatments

A fatal mix-up: How certain gut bacteria drive multiple sclerosis

New AI tool identifies not just genetic mutations, but the diseases they may cause

Deep-learning model predicts how fruit flies form, cell by cell